Osaka, Japan

Kazuo Okimoto

This inventor holds 1 USPTO granted patent. Top assignee: Dainippon Pharmaceutical Company, Limited. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuo Okimoto. Retrieved from https://idiyas.com/inventor/kazuo-okimoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kazuo Okimoto: Innovator in Neurodegenerative Disease Treatment

Introduction

Kazuo Okimoto is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of medicine, particularly in the prevention and treatment of neurodegenerative diseases. His innovative work has garnered attention and respect within the scientific community.

Latest Patents

Kazuo Okimoto holds 1 patent related to medicines aimed at combating neurodegenerative diseases. This patent reflects his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Okimoto is currently employed at Dainippon Pharmaceutical Company, Limited, where he continues to develop groundbreaking treatments. His work at this esteemed company has positioned him as a key player in the pharmaceutical industry.

Collaborations

Throughout his career, Okimoto has collaborated with notable colleagues, including Kiyoshi Furukawa and Satoshi Kurumiya. These partnerships have enhanced his research and contributed to the success of his projects.

Conclusion

Kazuo Okimoto's dedication to innovation in the medical field is evident through his patent and collaborative efforts. His work continues to pave the way for advancements in the treatment of neurodegenerative diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…